Medicare beneficiaries are expected to see lower Part B premiums in 2023 due to the lower price of Alzheimer's drug, Aduholm.

Today, Department of Health and Human Services Secretary Xavier Becerra said 2002 Medicare Part B premiums should be adjusted downward due to fact that the drug manufacturer reduced the price of Aduholm from $56,000 per year to $26,200 per year.

It is expected that the 2023 Part B premiums will be lower than in 2022, but a final determination will be made later this fall after CMS has assessed other current and projected Medicare Part B costs.

The Part B standard monthly premium increased from $148.50 in 2021 to $170.10 in 2022, due in part to spending trends driven by COVID-19 and uncertain pricing and utilization of Aduhelm, CMS said.